Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

EYP-1901 - Phase 2 | EYPT Pipeline | CatalystAlert

EYP-1901

Phase 2

EyePoint Pharmaceuticals, Inc. (EYPT)

17%

Phase 2

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Oct 2026~

EYPT⭐Phase 3Phase 2

EYP-1901 Phase 3 Results Expected

EYP-1901 • Diabetic Macular Edema

Aug 2026~

EYPT⭐Phase 3Phase 2

EYP-1901 Phase 3 Results Expected

EYP-1901 • Diabetic Macular Edema

Drug Information

Target Indication

Diabetic Macular Edema

Clinical Trial

Last updated: 12/4/2025

Developer

EYPT

EyePoint Pharmaceuticals, Inc.

Biotechnology•North America•NASDAQ